노인용 의약품 시장은 2024-2029년 573억 달러 증가하고, 예측 기간 동안 7.5%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
세계의 노인용 의약품 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 시장 환경 전반에 대한 최신 분석을 제공합니다. 이 시장은 노인 인구 증가, 개인 맞춤형 의료에 대한 수요, 정부 및 NGO의 노인 지원 증가에 의해 주도되고 있습니다.
| 시장 범위 |
| 기준 연도 |
2025년 |
| 종료 연도 |
2029년 |
| 예측 기간 |
2025-2029년 |
| 성장 모멘텀 |
가속 |
| 전년 대비 2025년 |
7.4% |
| CAGR |
7.5% |
| 증가액 |
573억 달러 |
이 조사는 업계 주요 참가자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역 분석에 따른 부문, 공급업체 상황, 주요 기업 분석이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.
이 보고서는 향후 몇 년동안 노인용 의약품 시장의 성장을 가속하는 주요 요인 중 하나로 치료 접근법 증가를 꼽았습니다. 또한, 전략적 제휴 및 인수, 노인의 건강 상태를 원격으로 모니터링하는 적극적인 역할 분담이 시장의 큰 수요로 이어질 것입니다.
목차
제1장 주요 요약
제2장 Technavio의 분석
- 가격, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 구도
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모 2024
- 시장 전망 2024-2029
제5장 시장 규모 실적
- 세계의 노인용 의약품 시장(2019-2023년)
- 유통 채널별 부문 분석(2019-2023년)
- 유형별 부문 분석(2019-2023년)
- 치료 영역별 부문 분석(2019-2023년)
- 폼팩터별 부문 분석(2019-2023년)
- 지역별 부문 분석(2019-2023년)
- 국가별 부문 분석(2019-2023년)
제6장 정성 분석
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제8장 시장 세분화 : 유통 채널별
- 시장 부문
- 비교 : 유통 채널별
- 병원 약국 : 시장 규모와 예측(2024-2029년)
- 소매 약국 : 시장 규모와 예측(2024-2029년)
- 온라인 약국 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 유통 채널별
제9장 시장 세분화 : 유형별
- 시장 부문
- 비교 : 유형별
- 진통제 : 시장 규모와 예측(2024-2029년)
- 당뇨병약 : 시장 규모와 예측(2024-2029년)
- 강압제 : 시장 규모와 예측(2024-2029년)
- 스타틴 : 시장 규모와 예측(2024-2029년)
- 기타 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 유형별
제10장 시장 세분화 : 치료 영역별
- 시장 부문
- 비교 : 치료 영역별
- 심장혈관 : 시장 규모와 예측(2024-2029년)
- 신경학 : 시장 규모와 예측(2024-2029년)
- 호흡기 : 시장 규모와 예측(2024-2029년)
- 기타 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 치료 영역별
제11장 시장 세분화 : 폼팩터별
- 시장 부문
- 비교 : 폼팩터별
- 알약 : 시장 규모와 예측(2024-2029년)
- 캡슐 : 시장 규모와 예측(2024-2029년)
- 액체 : 시장 규모와 예측(2024-2029년)
- 주사제 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 폼팩터별
제12장 고객 상황
제13장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측(2024-2029년)
- 유럽 : 시장 규모와 예측(2024-2029년)
- 아시아 : 시장 규모와 예측(2024-2029년)
- 세계 기타 지역 : 시장 규모와 예측(2024-2029년)
- 미국 : 시장 규모와 예측(2024-2029년)
- 캐나다 : 시장 규모와 예측(2024-2029년)
- 독일 : 시장 규모와 예측(2024-2029년)
- 중국 : 시장 규모와 예측(2024-2029년)
- 인도 : 시장 규모와 예측(2024-2029년)
- 영국 : 시장 규모와 예측(2024-2029년)
- 브라질 : 시장 규모와 예측(2024-2029년)
- 프랑스 : 시장 규모와 예측(2024-2029년)
- 이탈리아 : 시장 규모와 예측(2024-2029년)
- 스페인 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 지역 상황별
제14장 성장 촉진요인, 과제, 기회 및 성장 억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회와 성장 억제요인
제15장 경쟁 구도
제16장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- Abbott Laboratories
- AbbVie Inc.
- AstraZeneca Plc
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Co.
- Dr Reddys Laboratories Ltd.
- Eli Lilly and Co.
- Endo International Plc
- GlaxoSmithKline Plc
- Merck and Co. Inc.
- Novartis AG
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
- Sanofi SA
- Teva Pharmaceutical Industries Ltd.
제17장 부록
LSH
The geriatric medicines market is forecasted to grow by USD 57.3 billion during 2024-2029, accelerating at a CAGR of 7.5% during the forecast period. The report on the geriatric medicines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, demand for personalized medicine, and increase in governments and ngo supports for elderly.
| Market Scope |
|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 7.4% |
| CAGR | 7.5% |
| Incremental Value | $57.3 bn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's geriatric medicines market is segmented as below:
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
By Type
- Analgesics
- Antidiabetics
- Antihypertensives
- Statins
- Others
By Therapeutic Area
- Cardiovascular
- Neurology
- Respiratory
- Others
By Form Factor
- Tablets
- Capsules
- Liquids
- Injectables
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the rise in therapeutic approaches as one of the prime reasons driving the geriatric medicines market growth during the next few years. Also, strategic partnership and acquisitions and active role play of senior citizens in monitoring their health remotely will lead to sizable demand in the market.
The report on the geriatric medicines market covers the following areas:
- Geriatric Medicines Market sizing
- Geriatric Medicines Market forecast
- Geriatric Medicines Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading geriatric medicines market vendors that include Abbott Laboratories, AbbVie Inc., AstraZeneca PLC, Aurobindo Pharma Ltd., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cipla Inc., DR Reddys Laboratories Ltd., Eli Lilly and Co., Endo International PLC, GlaxoSmithKline PLC, Lupin Ltd., Merck and Co. Inc., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the geriatric medicines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Therapeutic Area
- Executive Summary - Chart on Market Segmentation by Form Factor
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Geriatric Medicines Market 2019 - 2023
- Historic Market Size - Data Table on Global Geriatric Medicines Market 2019 - 2023 ($ billion)
- 5.2 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion)
- 5.3 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ billion)
- 5.4 Therapeutic Area segment analysis 2019 - 2023
- Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ billion)
- 5.5 Form Factor segment analysis 2019 - 2023
- Historic Market Size - Form Factor Segment 2019 - 2023 ($ billion)
- 5.6 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
- 5.7 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Geriatric Medicines Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Distribution Channel
- 8.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
- 8.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 8.3 Hospital pharmacies - Market size and forecast 2024-2029
- Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ billion)
- Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ billion)
- Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- 8.4 Retail pharmacies - Market size and forecast 2024-2029
- Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ billion)
- Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ billion)
- Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- 8.5 Online pharmacies - Market size and forecast 2024-2029
- Chart on Online pharmacies - Market size and forecast 2024-2029 ($ billion)
- Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ billion)
- Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
- 8.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ billion)
- Data Table on Market opportunity by Distribution Channel ($ billion)
9 Market Segmentation by Type
- 9.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 9.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 9.3 Analgesics - Market size and forecast 2024-2029
- Chart on Analgesics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Analgesics - Market size and forecast 2024-2029 ($ billion)
- Chart on Analgesics - Year-over-year growth 2024-2029 (%)
- Data Table on Analgesics - Year-over-year growth 2024-2029 (%)
- 9.4 Antidiabetics - Market size and forecast 2024-2029
- Chart on Antidiabetics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Antidiabetics - Market size and forecast 2024-2029 ($ billion)
- Chart on Antidiabetics - Year-over-year growth 2024-2029 (%)
- Data Table on Antidiabetics - Year-over-year growth 2024-2029 (%)
- 9.5 Antihypertensives - Market size and forecast 2024-2029
- Chart on Antihypertensives - Market size and forecast 2024-2029 ($ billion)
- Data Table on Antihypertensives - Market size and forecast 2024-2029 ($ billion)
- Chart on Antihypertensives - Year-over-year growth 2024-2029 (%)
- Data Table on Antihypertensives - Year-over-year growth 2024-2029 (%)
- 9.6 Statins - Market size and forecast 2024-2029
- Chart on Statins - Market size and forecast 2024-2029 ($ billion)
- Data Table on Statins - Market size and forecast 2024-2029 ($ billion)
- Chart on Statins - Year-over-year growth 2024-2029 (%)
- Data Table on Statins - Year-over-year growth 2024-2029 (%)
- 9.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 9.8 Market opportunity by Type
- Market opportunity by Type ($ billion)
- Data Table on Market opportunity by Type ($ billion)
10 Market Segmentation by Therapeutic Area
- 10.1 Market segments
- Chart on Therapeutic Area - Market share 2024-2029 (%)
- Data Table on Therapeutic Area - Market share 2024-2029 (%)
- 10.2 Comparison by Therapeutic Area
- Chart on Comparison by Therapeutic Area
- Data Table on Comparison by Therapeutic Area
- 10.3 Cardiovascular - Market size and forecast 2024-2029
- Chart on Cardiovascular - Market size and forecast 2024-2029 ($ billion)
- Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ billion)
- Chart on Cardiovascular - Year-over-year growth 2024-2029 (%)
- Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%)
- 10.4 Neurology - Market size and forecast 2024-2029
- Chart on Neurology - Market size and forecast 2024-2029 ($ billion)
- Data Table on Neurology - Market size and forecast 2024-2029 ($ billion)
- Chart on Neurology - Year-over-year growth 2024-2029 (%)
- Data Table on Neurology - Year-over-year growth 2024-2029 (%)
- 10.5 Respiratory - Market size and forecast 2024-2029
- Chart on Respiratory - Market size and forecast 2024-2029 ($ billion)
- Data Table on Respiratory - Market size and forecast 2024-2029 ($ billion)
- Chart on Respiratory - Year-over-year growth 2024-2029 (%)
- Data Table on Respiratory - Year-over-year growth 2024-2029 (%)
- 10.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 10.7 Market opportunity by Therapeutic Area
- Market opportunity by Therapeutic Area ($ billion)
- Data Table on Market opportunity by Therapeutic Area ($ billion)
11 Market Segmentation by Form Factor
- 11.1 Market segments
- Chart on Form Factor - Market share 2024-2029 (%)
- Data Table on Form Factor - Market share 2024-2029 (%)
- 11.2 Comparison by Form Factor
- Chart on Comparison by Form Factor
- Data Table on Comparison by Form Factor
- 11.3 Tablets - Market size and forecast 2024-2029
- Chart on Tablets - Market size and forecast 2024-2029 ($ billion)
- Data Table on Tablets - Market size and forecast 2024-2029 ($ billion)
- Chart on Tablets - Year-over-year growth 2024-2029 (%)
- Data Table on Tablets - Year-over-year growth 2024-2029 (%)
- 11.4 Capsules - Market size and forecast 2024-2029
- Chart on Capsules - Market size and forecast 2024-2029 ($ billion)
- Data Table on Capsules - Market size and forecast 2024-2029 ($ billion)
- Chart on Capsules - Year-over-year growth 2024-2029 (%)
- Data Table on Capsules - Year-over-year growth 2024-2029 (%)
- 11.5 Liquids - Market size and forecast 2024-2029
- Chart on Liquids - Market size and forecast 2024-2029 ($ billion)
- Data Table on Liquids - Market size and forecast 2024-2029 ($ billion)
- Chart on Liquids - Year-over-year growth 2024-2029 (%)
- Data Table on Liquids - Year-over-year growth 2024-2029 (%)
- 11.6 Injectables - Market size and forecast 2024-2029
- Chart on Injectables - Market size and forecast 2024-2029 ($ billion)
- Data Table on Injectables - Market size and forecast 2024-2029 ($ billion)
- Chart on Injectables - Year-over-year growth 2024-2029 (%)
- Data Table on Injectables - Year-over-year growth 2024-2029 (%)
- 11.7 Market opportunity by Form Factor
- Market opportunity by Form Factor ($ billion)
- Data Table on Market opportunity by Form Factor ($ billion)
12 Customer Landscape
- 12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
- 13.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 13.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 13.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 13.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 13.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 13.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 13.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 13.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 13.9 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 13.10 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 13.11 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 13.12 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 13.13 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 13.14 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 13.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 13.16 Spain - Market size and forecast 2024-2029
- Chart on Spain - Market size and forecast 2024-2029 ($ billion)
- Data Table on Spain - Market size and forecast 2024-2029 ($ billion)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- 13.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)
14 Drivers, Challenges, and Opportunity/Restraints
- 14.1 Market drivers
- 14.2 Market challenges
- 14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 14.4 Market opportunities/restraints
15 Competitive Landscape
- 15.1 Overview
- 15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 15.3 Landscape disruption
- Overview on factors of disruption
- 15.4 Industry risks
- Impact of key risks on business
16 Competitive Analysis
- 16.1 Companies profiled
- 16.2 Company ranking index
- 16.3 Market positioning of companies
- Matrix on companies position and classification
- 16.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 16.5 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
- 16.6 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- 16.7 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
- 16.8 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
- 16.9 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
- 16.10 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- 16.11 Endo International Plc
- Endo International Plc - Overview
- Endo International Plc - Business segments
- Endo International Plc - Key news
- Endo International Plc - Key offerings
- Endo International Plc - Segment focus
- SWOT
- 16.12 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- 16.13 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- 16.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 16.15 Otsuka Holdings Co. Ltd.
- Otsuka Holdings Co. Ltd. - Overview
- Otsuka Holdings Co. Ltd. - Business segments
- Otsuka Holdings Co. Ltd. - Key news
- Otsuka Holdings Co. Ltd. - Key offerings
- Otsuka Holdings Co. Ltd. - Segment focus
- SWOT
- 16.16 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 16.17 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- 16.18 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- SWOT
17 Appendix
- 17.1 Scope of the report
- 17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 17.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 17.4 Research methodology
- 17.5 Data procurement
- 17.6 Data validation
- 17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 17.8 Data synthesis
- 17.9 360 degree market analysis
- 360 degree market analysis
- 17.10 List of abbreviations
